US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 10.510
  • +0.490+4.89%
Close Mar 14 16:00 ET
  • 10.900
  • +0.390+3.71%
Post 20:01 ET
383.58MMarket Cap-4.91P/E (TTM)

About Rapport Therapeutics Company

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Company Profile

SymbolRAPP
Company NameRapport Therapeutics
Listing DateJun 7, 2024
Issue Price17.00
Founded2022
CEOMr. Abraham N. Ceesay, M.B.A.
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address1325 Boylston Street,Suite 401
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-321-8020
Websitehttp://www.rapportrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Abraham N. Ceesay, M.B.A.
  • Chief Executive Officer and Director
  • 2.42M
  • Cheryl Gault
  • Chief Operating Officer
  • 1.78M
  • David Bredt, M.D.,PhD
  • Chief Scientific Officer and Director
  • --
  • Troy A. Ignelzi
  • Chief Financial Officer and Principal Accounting Officer
  • 2.13M
  • Dr. Swamy Yeleswaram, PhD
  • Chief Development Officer
  • --
  • Dr. Bradley S. Galer, M.D.
  • Chief Medical Officer
  • --
  • Kathy Wilkinson
  • Chief People Officer
  • --
  • Dr. Steven M. Paul, M.D.
  • Chairman of the Board
  • 568.99K
  • Dr. James I. Healy, M.D.,PhD
  • Director
  • --
  • Raymond Kelleher, M.D.,PhD
  • Director
  • --
  • Dr. Jeffrey K. Tong, PhD
  • Director
  • 55.50K
  • Wendy B. Young
  • Director
  • --
  • Dr. John M. Maraganore,PhD
  • Director
  • --
  • Robert J. Perez
  • Director
  • --
  • Paul M. Silva
  • Director
  • --
  • Dr. Reid M. Huber, PhD
  • Director
  • 400.26K
  • Dr. Raymond Sanchez, M.D.
  • Director
  • --
  • Terry-Ann Burrell, M.B.A.
  • Director
  • --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+13.00%
MARA Holdings
MARA
+8.39%
Petroleo Brasileiro SA Petrobras
PBR
+5.50%
NVIDIA
NVDA
+5.27%
Adobe
ADBE
+4.47%

Unlock the Full List